A novel orally administered trimebutine compound (GIC-1001) is anti-nociceptive and features peripheral opioid agonistic activity and Hydrogen Sulphide-releasing capacity in mice.
| Image |  |
|---|---|
| Description | scientific article published on 6 November 2015 |
| Author/s |
author: Nicolas Cenac Nathalie Vergnolle |
| Publication date | November 6, 2015 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |